Severe relapses and rebound activity after natalizumab discontinuation in MS patients with more than five years of treatment with stable disease course

被引：0
|
作者：
Fagius, J. [1 ]
Burman, J. [1 ]
Feresiadou, A. [1 ]
Larsson, E. -M. [2 ]
机构：
[1] Uppsala Univ, Neurosci Neurol, Uppsala, Sweden
[2] Uppsala Univ, Surg Sci Radiol, Uppsala, Sweden
来源：
MULTIPLE SCLEROSIS JOURNAL | 2015年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P618
引用
收藏
页码：297 / 297
页数：1
相关论文
共 50 条
  • [1] Recurrence or rebound of clinical relapses after discontinuation of natalizumab therapy in highly active MS patients
    Per Soelberg Sorensen
    Nils Koch-Henriksen
    Thor Petersen
    Mads Ravnborg
    Annette Oturai
    Finn Sellebjerg
    [J]. Journal of Neurology, 2014, 261 : 1170 - 1177
  • [2] Recurrence or rebound of clinical relapses after discontinuation of natalizumab therapy in highly active MS patients
    Sorensen, Per Soelberg
    Koch-Henriksen, Nils
    Petersen, Thor
    Ravnborg, Mads
    Oturai, Annette
    Sellebjerg, Finn
    [J]. JOURNAL OF NEUROLOGY, 2014, 261 (06) : 1170 - 1177
  • [3] Catastrophic outcome of patients with a rebound after Natalizumab treatment discontinuation
    Gonzalez-Suarez, Ines
    Rodriguez de Antonio, Luis
    Orviz, Aida
    Moreno-Garcia, Sara
    Valle-Arcos, Maria D.
    Matias-Guiu, Jordi A.
    Valencia, Cristina
    Jorquera Moya, Manuela
    Oreja-Guevara, Celia
    [J]. BRAIN AND BEHAVIOR, 2017, 7 (04):
  • [4] Disease activity after natalizumab discontinuation in multiple sclerosis: reactivation or rebound?
    Borriello, G.
    Prosperini, L.
    Mancinelli, C.
    Fubelli, F.
    Gianni, C.
    Marinelli, F.
    Pozzilli, C.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S228 - S228
  • [5] More than ten percent of relapses occur after five years in AML patients with NPM1 mutation
    Bertoli, Sarah
    Tavitian, Suzanne
    Berard, Emilie
    Mansat-De Mas, Veronique
    Largeaud, Laetitia
    Gadaud, Noemie
    Rieu, Jean-Baptiste
    Vergez, Francois
    Luquet, Isabelle
    Huguet, Francoise
    Sarry, Audrey
    Delabesse, Eric
    Recher, Christian
    [J]. LEUKEMIA & LYMPHOMA, 2020, 61 (05) : 1226 - 1229
  • [6] Disease activity after natalizumab discontinuation: a retrospective study from two Italian MS centers
    Lo Re, M.
    Ragonese, P.
    Capobianco, M.
    Malucchi, S.
    Realmuto, S.
    Matta, M.
    Salemi, G.
    Bertolotto, A.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 298 - 299
  • [7] Recurrence of disease activity after fingolimod discontinuation in older patients previously stable on treatment
    Pantazou, Vasiliki
    Pot, Caroline
    Du Pasquier, Renaud
    Le Goff, Geraldine
    Theaudin, Marie
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 51
  • [8] Rebound of disease activity after discontinuation of natalizumab or fingolimod can be successfully treated with autologous haematopoietic stem cell transplantation
    Curro, D.
    Gualandi, F.
    Cavalla, P.
    Capello, E.
    Uccelli, A.
    Mattioda, A.
    Boffa, G.
    Mancardi, G.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 621 - 622
  • [9] Prevalence of lymphoedema more than five years after breast cancer treatment
    Penha, T. R. Lopez
    Slangen, J. J. G.
    Heuts, E. M.
    Voogd, A. C.
    von Meyenfeldt, M. F.
    [J]. EJSO, 2011, 37 (12): : 1059 - 1063
  • [10] Reactivation of disease activity in patients with multiple sclerosis after Natalizumab discontinuation: a case report in Venezuela
    Soto, I
    Ferrer, O.
    Molina, O.
    Mora, E.
    Villalobos, V.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (12) : 1860 - 1860
12345